Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Insights

Clinical Insights
The CROSSFIRE Study of Irreversible Electroporation for Pancreatic Cancer: Can IRE Improve Survival?
12/27/2015
Irreversible electroporation (IRE) is a promising new ablation technique to fight pancreatic cancer. Cell death is achieved by delivering high-voltage pulses. The CROSSFIRE trial is an international phase 3, multicenter, randomized controlled...
Irreversible electroporation (IRE) is a promising new ablation technique to fight pancreatic cancer. Cell death is achieved by delivering high-voltage pulses. The CROSSFIRE trial is an international phase 3, multicenter, randomized controlled...
Irreversible electroporation...
12/27/2015
IO Learning
Clinical Insights
A Collaborative Endeavor: Synergy and the Association for Radiologic & Imaging Nursing
12/24/2015
Synergy: A Multidisciplinary Approach to Interventional Oncology hosted its 5th annual meeting this year in Miami, Florida, November 5-8, 2015. As the meeting’s name suggests, a multidisciplinary approach to interventional oncology (IO) is...
Synergy: A Multidisciplinary Approach to Interventional Oncology hosted its 5th annual meeting this year in Miami, Florida, November 5-8, 2015. As the meeting’s name suggests, a multidisciplinary approach to interventional oncology (IO) is...
Synergy: A Multidisciplinary...
12/24/2015
IO Learning
Clinical Insights
Photothermal Ablation: A Perspective on Technique
12/23/2015
Abstract: Limitations in methodology and inaccessible location of tumors have prevented widespread implementation of hyperthermia as a therapeutic option. However, hyperthermia achieved with photothermal ablation (PTA) paired with...
Abstract: Limitations in methodology and inaccessible location of tumors have prevented widespread implementation of hyperthermia as a therapeutic option. However, hyperthermia achieved with photothermal ablation (PTA) paired with...
Abstract: Limitations in...
12/23/2015
IO Learning
Clinical Insights
Endovascular Radiofrequency Neurolysis for Refractory Abdominal Cancer Pain
11/30/2015
Endovascular radiofrequency neurolysis was originally developed on the basis of our experience with endovascular renal artery denervation for treatment of resistant hypertension. In 2014 we began to study the use of endovascular celiac artery...
Endovascular radiofrequency neurolysis was originally developed on the basis of our experience with endovascular renal artery denervation for treatment of resistant hypertension. In 2014 we began to study the use of endovascular celiac artery...
Endovascular radiofrequency...
11/30/2015
IO Learning
Clinical Insights
Local Delivery of Gene-Based Therapy for Hepatocellular Carcinoma: The TACE of the Future?
11/24/2015
From the 1Department of Biomedical Engineering, and the Translational Tissue Engineering Center, Johns Hopkins University, Baltimore, Maryland, and the Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de...
From the 1Department of Biomedical Engineering, and the Translational Tissue Engineering Center, Johns Hopkins University, Baltimore, Maryland, and the Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de...
From the 1Department of...
11/24/2015
IO Learning
Clinical Insights
Interventional Management of Hepatocellular Carcinoma: Articles From the Official Show Daily for Synergy 2015
11/11/2015
Interventional locoregional treatments play a key role in the management of hepatocellular carcinoma (HCC). Image-guided percutaneous ablation is recommended in patients with early-stage HCC when surgical options are precluded and can replace...
Interventional locoregional treatments play a key role in the management of hepatocellular carcinoma (HCC). Image-guided percutaneous ablation is recommended in patients with early-stage HCC when surgical options are precluded and can replace...
Interventional locoregional...
11/11/2015
IO Learning
Clinical Insights
Cone-Beam Computed Tomography to Assist in DEB-TACE for HCC in the Caudate Lobe
10/23/2015
Abstract: Transarterial chemoembolization (TACE) plays an important role in the treatment of hepatocellular carcinoma (HCC). Recognition of the tumor arterial supply is necessary to perform effective TACE. In this sense cone-beam computed...
Abstract: Transarterial chemoembolization (TACE) plays an important role in the treatment of hepatocellular carcinoma (HCC). Recognition of the tumor arterial supply is necessary to perform effective TACE. In this sense cone-beam computed...
Abstract: Transarterial...
10/23/2015
IO Learning
Clinical Insights
Advances in the Treatment of Early Stage Non-Small Cell Lung Cancer Using Stereotactic Radiation Therapy
09/30/2015
Abstract: Surgery is still the most commonly used treatment for early-stage non-small cell lung cancer (NSCLC). However, many patients with NSCLC have significant comorbidities and are not surgical candidates. Radiation therapy has...
Abstract: Surgery is still the most commonly used treatment for early-stage non-small cell lung cancer (NSCLC). However, many patients with NSCLC have significant comorbidities and are not surgical candidates. Radiation therapy has...
Abstract: Surgery is still the...
09/30/2015
IO Learning
Clinical Insights
The Importance of Embolic Material and Artery Selection During Transarterial Chemoembolization of Hepatocellular Carcinoma
09/28/2015
Abstract: The embolization technique and materials used for transarterial chemoembolization (TACE) vary widely and are often chosen on a case-by-case basis. A combination of factors, most importantly the size and location of the tumor(s),...
Abstract: The embolization technique and materials used for transarterial chemoembolization (TACE) vary widely and are often chosen on a case-by-case basis. A combination of factors, most importantly the size and location of the tumor(s),...
Abstract: The embolization...
09/28/2015
IO Learning
Clinical Insights
Glass Microspheres for Colorectal Metastases to the Liver: An Interview With Ryan Hickey, MD, and Robert Lewandowski, MD
08/28/2015
At the 2015 Annual Scientific Meeting of the Society of Interventional Radiology (SIR), Ryan Hickey, MD, and Robert Lewandowski, MD, interventional radiologists from Northwestern University in Chicago, presented data on outcomes of glass...
At the 2015 Annual Scientific Meeting of the Society of Interventional Radiology (SIR), Ryan Hickey, MD, and Robert Lewandowski, MD, interventional radiologists from Northwestern University in Chicago, presented data on outcomes of glass...
At the 2015 Annual Scientific...
08/28/2015
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement